Provided by Tiger Trade Technology Pte. Ltd.

Tandem Diabetes Care

16.50
0.0000
Post-market: 16.590.0883+0.54%17:20 EDT
Volume:2.19M
Turnover:36.56M
Market Cap:1.15B
PE:-17.79
High:17.35
Open:16.66
Low:16.27
Close:16.50
52wk High:29.65
52wk Low:12.26
Shares:69.58M
Float Shares:63.59M
Volume Ratio:0.90
T/O Rate:3.45%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9274
EPS(LYR):-3.0424
ROE:-48.03%
ROA:-2.65%
PB:8.80
PE(LYR):-5.42

Loading ...

Stock Track | Tandem Diabetes Care Soars 8.23% in Pre-market on Strong Q1 Earnings Beat and Improved Outlook

Stock Track
·
May 08

Stock Track | Tandem Diabetes Care Soars 11.53% Intraday on Better-Than-Expected Q1 Results and Improved Outlook

Stock Track
·
May 08

Buy Rating Reaffirmed on Tandem Diabetes Care as Fundamentals Strengthen; $28 Price Target Maintained

TIPRANKS
·
May 08

Tandem Diabetes Care Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 08

Stock Track | Tandem Diabetes Care Soars 9.64% After-Hours on Better-Than-Expected Q1 Results

Stock Track
·
May 08

Tandem Diabetes FY26 Q1 net loss narrows to $20.4 million; sales rise 5% to $247.2 million

Reuters
·
May 08

BRIEF-Tandem Diabetes Care Q1 Gross Margin 55%

Reuters
·
May 08

Tandem Diabetes Care Inc - Reports Q1 2026 Results and Reaffirms 2026 Financial Guidance

THOMSON REUTERS
·
May 08

Earning Preview: Tandem Diabetes Care this quarter’s revenue is expected to increase by 9.19%, and institutional views are bullish

Earnings Agent
·
Apr 30

Tandem Diabetes Care to present at BofA Securities Health Care Conference

Reuters
·
Apr 30

Tandem Diabetes Care’s Control-Iq+ Automated Insulin Delivery Technology NOW FDA Cleared for Pregnancy in Type 1 Diabetes

THOMSON REUTERS
·
Apr 27

Tandem Control-IQ+ wins FDA clearance for use in pregnancy with type 1 diabetes

Reuters
·
Apr 27

Tandem Diabetes price target raised to $45 from $36 at Rothschild & Co Redburn

TIPRANKS
·
Apr 24

Tandem Diabetes Care Is Maintained at Buy by TD Cowen

Dow Jones
·
Apr 20

Leveraging Rx Channel Shift and Mobi Tubeless Launch to Drive Sustainable Growth at Tandem Diabetes Care

TIPRANKS
·
Apr 20

Analysts Have Conflicting Sentiments on These Healthcare Companies: Tandem Diabetes Care (TNDM) and Qiagen (QGEN)

TIPRANKS
·
Apr 15

Tandem Diabetes Care Is Maintained at Neutral by Goldman Sachs

Dow Jones
·
Apr 10

Citi adds ‘upside 90-day catalyst watch’ on Tandem Diabetes

TIPRANKS
·
Apr 07